-
Je něco špatně v tomto záznamu ?
Incarceration history is associated with HIV infection among community-recruited people who inject drugs in Europe: A propensity-score matched analysis of cross-sectional studies
A. Uusküla, J. Rannap, L. Weijler, A. Abagiu, V. Arendt, G. Barrio, H. Barros, H. Brummer-Korvenkontio, J. Casabona, E. Croes, DD. Jarlais, C. Seguin-Devaux, M. Dudás, K. Eritsyan, C. Folch, A. Hatzakis, R. Heimer, E. Heinsbroek, V. Hope, R....
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
WT 226619/Z/22/Z
Wellcome Trust - United Kingdom
NLK
CINAHL Plus with Full Text (EBSCOhost)
od 2003-03-01 do Před 1 rokem
Medline Complete (EBSCOhost)
od 1993-01-01 do Před 1 rokem
PubMed
37991429
DOI
10.1111/add.16283
Knihovny.cz E-zdroje
- MeSH
- HIV infekce * epidemiologie MeSH
- HIV séropozitivita * MeSH
- intravenózní abúzus drog * epidemiologie MeSH
- lidé MeSH
- průřezové studie MeSH
- tendenční skóre MeSH
- uživatelé drog * MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Geografické názvy
- Evropa MeSH
AIMS: We measured the association between a history of incarceration and HIV positivity among people who inject drugs (PWID) across Europe. DESIGN, SETTING AND PARTICIPANTS: This was a cross-sectional, multi-site, multi-year propensity-score matched analysis conducted in Europe. Participants comprised community-recruited PWID who reported a recent injection (within the last 12 months). MEASUREMENTS: Data on incarceration history, demographics, substance use, sexual behavior and harm reduction service use originated from cross-sectional studies among PWID in Europe. Our primary outcome was HIV status. Generalized linear mixed models and propensity-score matching were used to compare HIV status between ever- and never-incarcerated PWID. FINDINGS: Among 43 807 PWID from 82 studies surveyed (in 22 sites and 13 countries), 58.7% reported having ever been in prison and 7.16% (n = 3099) tested HIV-positive. Incarceration was associated with 30% higher odds of HIV infection [adjusted odds ratio (aOR) = 1.32, 95% confidence interval (CI) = 1.09-1.59]; the association between a history of incarceration and HIV infection was strongest among PWID, with the lowest estimated propensity-score for having a history of incarceration (aOR = 1.78, 95% CI = 1.47-2.16). Additionally, mainly injecting cocaine and/or opioids (aOR = 2.16, 95% CI = 1.33-3.53), increased duration of injecting drugs (per 8 years aOR = 1.31, 95% CI = 1.16-1.48), ever sharing needles/syringes (aOR = 1.91, 95% CI = 1.59-2.28) and increased income inequality among the general population (measured by the Gini index, aOR = 1.34, 95% CI = 1.18-1.51) were associated with a higher odds of HIV infection. Older age (per 8 years aOR = 0.84, 95% CI = 0.76-0.94), male sex (aOR = 0.77, 95% CI = 0.65-0.91) and reporting pharmacies as the main source of clean syringes (aOR = 0.72, 95% CI = 0.59-0.88) were associated with lower odds of HIV positivity. CONCLUSIONS: A history of incarceration appears to be independently associated with HIV infection among people who inject drugs (PWID) in Europe, with a stronger effect among PWID with lower probability of incarceration.
Agència de Salut Pública de Barcelona Barcelona Spain
Blood Safety Hepatitis STI and HIV Division UK Health Security Agency London UK
Department of Computational Biology University of Lausanne Lausanne Switzerland
Department of Infection and Immunity Luxembourg Institute of Health Luxembourg
Department of Infectious Diseases Public Health Service of Amsterdam Amsterdam the Netherlands
EMCDDA Polish National Focal Point National Bureau for Drug Prevention Warsaw Poland
EPIUnit Instituto de Saúde Pública Universidade do Porto Porto Portugal
European Monitoring Centre for Drugs and Drug Addiction Lisbon Portugal
Finnish Institute for Health and Welfare Helsinki Finland
Hungarian Reitox National Focal Point Budapest Hungary
Institute of Family Medicine and Public Health University of Tartu Tartu Estonia
Institute of Public Health Riga Stradins University Riga Latvia
Klinika Podané ruce Brno Czech Republic
National Drug and Alcohol Research Centre the University of New South Wales Sydney NSW Australia
National Institute for Infectious diseases 'Professor Dr Matei Bals' Bucharest Romania
National Public Health Center Budapest Hungary
National Research University Higher School of Economics St Petersburg Russia
National School of Public Health Carlos 3 Health Institute Madrid Spain
Non Profit Partnership ESVERO 12 Moscow Russia
Population Health Sciences Bristol Medical School University of Bristol Bristol UK
Public Health Institute Liverpool John Moores University Liverpool UK
Public Health Scotland Meridian Court Glasgow Scotland UK
School of Global Public Health New York University New York NY 10012 USA
School of Health and Life Sciences Glasgow Caledonian University Glasgow Scotland UK
Service National des Maladies Infectieuses Centre Hospitalier de Luxembourg Luxembourg
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24000764
- 003
- CZ-PrNML
- 005
- 20240213093350.0
- 007
- ta
- 008
- 240109s2023 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/add.16283 $2 doi
- 035 __
- $a (PubMed)37991429
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Uusküla, Anneli $u Institute of Family Medicine and Public Health, University of Tartu, Tartu, Estonia $1 https://orcid.org/0000000240363856
- 245 10
- $a Incarceration history is associated with HIV infection among community-recruited people who inject drugs in Europe: A propensity-score matched analysis of cross-sectional studies / $c A. Uusküla, J. Rannap, L. Weijler, A. Abagiu, V. Arendt, G. Barrio, H. Barros, H. Brummer-Korvenkontio, J. Casabona, E. Croes, DD. Jarlais, C. Seguin-Devaux, M. Dudás, K. Eritsyan, C. Folch, A. Hatzakis, R. Heimer, E. Heinsbroek, V. Hope, R. Jipa, A. Ķīvīte-Urtāne, O. Levina, A. Lyubimova, A. Malczewski, A. Matser, A. McAuley, P. Meireles, V. Mravčík, E. Op de Coul, SE. Ojavee, O. Parés-Badell, M. Prins, J. Pulido, E. Romanyak, M. Rosinska, T. Seyler, J. Stone, V. Sypsa, A. Talu, A. Tarján, A. Taylor, P. Vickerman, S. Vorobjov, K. Dolan, L. Wiessing, EMCDDA study group
- 520 9_
- $a AIMS: We measured the association between a history of incarceration and HIV positivity among people who inject drugs (PWID) across Europe. DESIGN, SETTING AND PARTICIPANTS: This was a cross-sectional, multi-site, multi-year propensity-score matched analysis conducted in Europe. Participants comprised community-recruited PWID who reported a recent injection (within the last 12 months). MEASUREMENTS: Data on incarceration history, demographics, substance use, sexual behavior and harm reduction service use originated from cross-sectional studies among PWID in Europe. Our primary outcome was HIV status. Generalized linear mixed models and propensity-score matching were used to compare HIV status between ever- and never-incarcerated PWID. FINDINGS: Among 43 807 PWID from 82 studies surveyed (in 22 sites and 13 countries), 58.7% reported having ever been in prison and 7.16% (n = 3099) tested HIV-positive. Incarceration was associated with 30% higher odds of HIV infection [adjusted odds ratio (aOR) = 1.32, 95% confidence interval (CI) = 1.09-1.59]; the association between a history of incarceration and HIV infection was strongest among PWID, with the lowest estimated propensity-score for having a history of incarceration (aOR = 1.78, 95% CI = 1.47-2.16). Additionally, mainly injecting cocaine and/or opioids (aOR = 2.16, 95% CI = 1.33-3.53), increased duration of injecting drugs (per 8 years aOR = 1.31, 95% CI = 1.16-1.48), ever sharing needles/syringes (aOR = 1.91, 95% CI = 1.59-2.28) and increased income inequality among the general population (measured by the Gini index, aOR = 1.34, 95% CI = 1.18-1.51) were associated with a higher odds of HIV infection. Older age (per 8 years aOR = 0.84, 95% CI = 0.76-0.94), male sex (aOR = 0.77, 95% CI = 0.65-0.91) and reporting pharmacies as the main source of clean syringes (aOR = 0.72, 95% CI = 0.59-0.88) were associated with lower odds of HIV positivity. CONCLUSIONS: A history of incarceration appears to be independently associated with HIV infection among people who inject drugs (PWID) in Europe, with a stronger effect among PWID with lower probability of incarceration.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 12
- $a HIV infekce $x epidemiologie $7 D015658
- 650 _2
- $a průřezové studie $7 D003430
- 650 12
- $a uživatelé drog $7 D055030
- 650 12
- $a intravenózní abúzus drog $x epidemiologie $7 D015819
- 650 12
- $a HIV séropozitivita $7 D006679
- 650 _2
- $a tendenční skóre $7 D057216
- 651 _2
- $a Evropa $x epidemiologie $7 D005060
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Rannap, Jürgen $u Institute of Family Medicine and Public Health, University of Tartu, Tartu, Estonia
- 700 1_
- $a Weijler, Lisa $u European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon, Portugal
- 700 1_
- $a Abagiu, Adrian $u National Institute for Infectious diseases 'Professor Dr Matei Bals', Bucharest, Romania
- 700 1_
- $a Arendt, Vic $u Service National des Maladies Infectieuses, Centre Hospitalier de Luxembourg, Luxembourg
- 700 1_
- $a Barrio, Gregorio $u National School of Public Health, Carlos III Health Institute, Madrid, Spain $1 https://orcid.org/0000000262573213
- 700 1_
- $a Barros, Henrique $u EPIUnit-Instituto de Saúde Pública, Universidade do Porto, Porto, Portugal
- 700 1_
- $a Brummer-Korvenkontio, Henrikki $u Finnish Institute for Health and Welfare, Helsinki, Finland
- 700 1_
- $a Casabona, Jordi $u Centre for Epidemiological Studies on Sexually Transmitted Infections and HIV/AIDS of Catalonia (CEEISCAT), Catalonia Public Health Agency (ASPCAT), Badalona, Spain $u Biomedical Research Networking Centre in Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain
- 700 1_
- $a Croes, Esther $u Trimbos Institute, Utrecht, the Netherlands
- 700 1_
- $a Jarlais, Don Des $u School of Global Public Health, New York University, New York, NY, 10012, USA
- 700 1_
- $a Seguin-Devaux, Carole $u Department of Infection and Immunity, Luxembourg Institute of Health, Luxembourg
- 700 1_
- $a Dudás, Mária $u National Public Health Center, Budapest, Hungary
- 700 1_
- $a Eritsyan, Ksenia $u National Research University Higher School of Economics, St Petersburg, Russia
- 700 1_
- $a Folch, Cinta $u Centre for Epidemiological Studies on Sexually Transmitted Infections and HIV/AIDS of Catalonia (CEEISCAT), Catalonia Public Health Agency (ASPCAT), Badalona, Spain $u Biomedical Research Networking Centre in Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain
- 700 1_
- $a Hatzakis, Angelos $u Department of Hygiene, Epidemiology and Medical Statistics, National and Kapodistrian University of Athens, Medical School, Athens, Greece
- 700 1_
- $a Heimer, Robert $u Department of the Epidemiology of Microbial Diseases, Center for Interdisciplinary Research on AIDS, Yale School of Public Health, New Haven, CT, USA
- 700 1_
- $a Heinsbroek, Ellen $u Blood Safety, Hepatitis, STI & HIV Division, UK Health Security Agency, London, UK
- 700 1_
- $a Hope, Vivian $u Blood Safety, Hepatitis, STI & HIV Division, UK Health Security Agency, London, UK $u Public Health Institute, Liverpool John Moores University, Liverpool, UK
- 700 1_
- $a Jipa, Raluca $u National Institute for Infectious diseases 'Professor Dr Matei Bals', Bucharest, Romania
- 700 1_
- $a Ķīvīte-Urtāne, Anda $u Institute of Public Health, Riga Stradins University, Riga, Latvia
- 700 1_
- $a Levina, Olga $u National Research University Higher School of Economics, St Petersburg, Russia $u Acuity Systems, Herndon, VA, USA
- 700 1_
- $a Lyubimova, Alexandra $u National Research University Higher School of Economics, St Petersburg, Russia
- 700 1_
- $a Malczewski, Artur $u EMCDDA Polish National Focal Point, National Bureau for Drug Prevention, Warsaw, Poland
- 700 1_
- $a Matser, Amy $u Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, the Netherlands $u Amsterdam UMC, University of Amsterdam, Department of Infectious Diseases, Amsterdam Infection andd Immunity Institute, Amsterdam, the Netherlands
- 700 1_
- $a McAuley, Andrew $u Public Health Scotland, Meridian Court, Glasgow, Scotland, UK $u School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, Scotland, UK
- 700 1_
- $a Meireles, Paula $u EPIUnit-Instituto de Saúde Pública, Universidade do Porto, Porto, Portugal
- 700 1_
- $a Mravčík, Viktor $u Department of Addictology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic $u Společnost Podané ruce, Brno, Czech Republic $u Klinika Podané ruce, Brno, Czech Republic
- 700 1_
- $a Op de Coul, Eline $u Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands
- 700 1_
- $a Ojavee, Sven E $u Department of Computational Biology, University of Lausanne, Lausanne, Switzerland
- 700 1_
- $a Parés-Badell, Oleguer $u Agència de Salut Pública de Barcelona, Barcelona, Spain
- 700 1_
- $a Prins, Maria $u Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, the Netherlands $u Amsterdam UMC, University of Amsterdam, Department of Infectious Diseases, Amsterdam Infection andd Immunity Institute, Amsterdam, the Netherlands
- 700 1_
- $a Pulido, José $u National School of Public Health, Carlos III Health Institute, Madrid, Spain $u Biomedical Research Networking Centre in Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain $u Department of Public Health and Maternal and Child Health, Complutense University of Madrid, Madrid, Spain
- 700 1_
- $a Romanyak, Elena $u Non-Profit Partnership ESVERO, 12, Moscow, Russia
- 700 1_
- $a Rosinska, Magdalena $u Department of Infectious Diseases Epidemiology and Surveillance, National Institute of Public Health NIH, National Research Institute, Warsaw, Poland
- 700 1_
- $a Seyler, Thomas $u European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon, Portugal
- 700 1_
- $a Stone, Jack $u Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK
- 700 1_
- $a Sypsa, Vana $u Department of Hygiene, Epidemiology and Medical Statistics, National and Kapodistrian University of Athens, Medical School, Athens, Greece
- 700 1_
- $a Talu, Ave $u Institute of Family Medicine and Public Health, University of Tartu, Tartu, Estonia
- 700 1_
- $a Tarján, Anna $u Hungarian Reitox National Focal Point, Budapest, Hungary
- 700 1_
- $a Taylor, Avril $u Emeritus Professor of Public Health, School of Education and Social Sciences, University of West Scotland, Paisley, Scotland, UK
- 700 1_
- $a Vickerman, Peter $u Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK
- 700 1_
- $a Vorobjov, Sigrid $u Department of Drug and Infectious Diseases Epidemiology, National Institute for Health Development, Tallinn, Estonia
- 700 1_
- $a Dolan, Kate $u National Drug and Alcohol Research Centre, the University of New South Wales, Sydney, NSW, Australia
- 700 1_
- $a Wiessing, Lucas $u European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon, Portugal $1 https://orcid.org/0000000220782826
- 710 2_
- $a EMCDDA study group
- 773 0_
- $w MED00000153 $t Addiction $x 1360-0443 $g Roč. 118, č. 11 (2023), s. 2177-2192
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37991429 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240109 $b ABA008
- 991 __
- $a 20240213093347 $b ABA008
- 999 __
- $a ok $b bmc $g 2049408 $s 1210458
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 118 $c 11 $d 2177-2192 $e 20230803 $i 1360-0443 $m Addiction $n Addiction $x MED00000153
- GRA __
- $a WT 226619/Z/22/Z $p Wellcome Trust $2 United Kingdom
- LZP __
- $a Pubmed-20240109
